Oxford: The Oxford Cowed-19 vaccine has been claimed to have 70% success in the trial phase. | pakipolitics.com
The UK-developed corona virus vaccine can protect 70.4% of people from getting code-19, and data show that 90% of people can be protected from low-dose use. The results of the vaccine trial phase by Oxford University and pharmaceutical company AstraZeneca are being hailed as a great success. Oxford University and pharmaceutical company AstraZeneca have announced
